help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duncan, G. E.
Right arrow Articles by Stacpoole, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duncan, G. E.
Right arrow Articles by Stacpoole, P. W.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 4 1733-1738
Copyright © 2004 by The Endocrine Society

Dichloroacetate Therapy Attenuates the Blood Lactate Response to Submaximal Exercise in Patients with Defects in Mitochondrial Energy Metabolism

G. E. Duncan, L. A. Perkins, D. W. Theriaque, R. E. Neiberger and P. W. Stacpoole

Department of Epidemiology, Nutritional Sciences Program, University of Washington (G.E.D.), Seattle, Washington 98195; and Departments of Medicine (L.A.P., P.W.S.), Pediatrics (R.E.N.), and Biochemistry and Molecular Biology (P.W.S.), and General Clinical Research Center (D.W.T.), University of Florida, Gainesville, Florida 32610

Address all correspondence and requests for reprints to: Dr. G. E. Duncan, 305 Raitt Hall, Box 353410, University of Washington, Seattle, Washington 98195. E-mail: duncag{at}u.washington.edu.

We determined acute and chronic effects of dichloroacetate (DCA) on maximal (MAX) and submaximal (SUB) exercise responses in patients with abnormal mitochondrial energetics. Subjects (n = 9) completed a MAX treadmill bout 1 h after ingesting 25 mg/kg DCA or placebo (PL). A 15-min SUB bout was completed the next day while receiving the same treatment. After a 1-d washout, MAX and SUB were repeated while receiving the alternate treatment (acute). Gas exchange and heart rate were measured throughout all tests. Blood lactate (Bla) was measured 0, 3, and 10 min after MAX, and 5, 10, and 15 min during SUB. MAX and SUB were repeated after 3 months of daily DCA or PL. After a 2-wk washout, a final MAX and SUB were completed after 3 months of alternate treatment (chronic). Average Bla during SUB was lower (P < 0.05) during both acute (1.99 ± 1.10 vs. 2.49 ± 1.52 mmol/liter) and chronic (1.71 ± 1.37 vs. 2.39 ± 1.32 mmol/liter) DCA vs. PL despite similar exercise intensities between conditions (~75 and 70% maximal exercise capacity during acute and chronic treatment). Thus, although DCA does not alter MAX responses, acute and chronic DCA attenuate the Bla response to moderate exercise in patients with abnormal mitochondrial energetics.

This work was supported by American Heart Association Grant 9920174V and NIH Grants ES-07355 and RR-00082.

Abbreviations: Bla, Blood lactate; DCA, dichloroacetate; HR, heart rate; MAX, maximal; NCV, nerve conduction velocity; PDC, pyruvate dehydrogenase complex; PL, placebo; RPE, rating of perceived exertion scale; SUB, submaximal; VO2peak, maximal exercise capacity.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society